STAR and breast neoplasm: Noteworthy, inhibition of StAR expression, corresponding with a reduction in E2 biosynthesis, by a variety of HDACIs, in both hormone-sensitive human MCF7 cells and mouse enriched breast tumor epithelial cells, demonstrated that StAR could be targeted for combating ER+ BC.